Stock Comparison

VRDN vs VRTX

Viridian Therapeutics Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

VRDN

Viridian Therapeutics Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$2.55B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

1.0

25.7

Price/Sales

35.8

9.9

Price/Book

4.5

6.1

EV/EBITDA

-3.0

23.2

Dividend Yield

—

Profitability

Net Margin

-508.46%

35.40%

Operating Margin

-543.86%

38.97%

Return on Equity

-65.70%

23.50%

Return on Assets

-30.20%

11.90%

Growth (YoY)

Revenue Growth

278.70%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

0.9

0.3

52-Week High

$33.78

$529.65

52-Week Low

$13.30

$376.62

Analyst Target

$36.62

$559.28

Compare VRDN and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.